NCT04329039View on ClinicalTrials.gov

Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

February 7, 2025

Study Completion Date

December 31, 2026

Conditions

Pancreatic Diseases

Interventions

DRUG

Somatostatin analog

Somatostatin analog plus perioperative antibiotics Placebo plus perioperative antibiotics

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04329039 - Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics | Biotech Hunter | Biotech Hunter